8158.HK Stock Analysis
81
Uncovered
China Regenerative Medicine International Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. The company employs 21 full-time employees The company went IPO on 2001-07-18. Along with subsidiaries, the Company operates its business through four segments. The Medical Equipment segment is involved in trading of medical equipments. The Tissue Engineering segment is involved in production and sale of tissue engineering products. The Cosmetic and Others segment is involved in production and sales of cosmetic, healthcare and other products. The Stem Cell segment is involved in research of cellular and stem cell therapy, sales and distribution of stem cell medical equipment, as well as the provision of other services.